Demant A/S (LON:0RGT)

Market Cap	4.51B -36.7%
Revenue (ttm)	2.68B +2.5%
Net Income	180.47M -35.3%
EPS	0.85 -33.5%
Shares Out	n/a
PE Ratio	24.97
Forward PE	14.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,432
Average Volume	46,990
Open	190.95
Previous Close	194.19
Day's Range	184.20 - 192.50
52-Week Range	184.20 - 292.80
Beta	0.88
RSI	25.90
Earnings Date	Feb 3, 2026

About Demant

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1904
• Employees: 22,057
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RGT

Financial Performance

In 2025, Demant's revenue was 22.97 billion, an increase of 2.46% compared to the previous year's 22.42 billion. Earnings were 1.55 billion, a decrease of -35.27%.

Financial numbers in DKK